标题
Systematic review: safety of mesalazine in ulcerative colitis
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 47, Issue 12, Pages 1597-1609
出版商
Wiley
发表日期
2018-05-03
DOI
10.1111/apt.14688
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis
- (2017) Yasuo Suzuki et al. INFLAMMATORY BOWEL DISEASES
- Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Remission Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study
- (2016) Jing Sun et al. ADVANCES IN THERAPY
- Once dailyvsmultiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis
- (2016) W. Li et al. Colorectal Disease
- Maintenance therapy options for ulcerative colitis
- (2016) María Chaparro et al. EXPERT OPINION ON PHARMACOTHERAPY
- Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors
- (2016) Salam F. Zakko et al. POSTGRADUATE MEDICINE
- Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease
- (2016) Yasuo Suzuki et al. Drugs in research & development
- Mesalazine-induced eosinophilic pneumonia in a patient with ulcerative colitis disease: a case report and literature review
- (2015) Ana Isabel Franco et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity
- (2015) José Ferrusquía WORLD JOURNAL OF GASTROENTEROLOGY
- Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis
- (2015) Kathryn Fleming et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Lung disease and ulcerative colitis − mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease?
- (2015) A. Moeser et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
- (2015) Cristiana Perrotta et al. Gastroenterology Research and Practice
- The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease
- (2014) A. M. Schoepfer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
- (2014) Leo Russo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term Safety and Tolerability of Once-daily Mesalamine Granules in the Maintenance of Remission of Ulcerative Colitis
- (2014) Gary R. Lichtenstein et al. INFLAMMATORY BOWEL DISEASES
- Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility
- (2014) Takeshi Shin et al. Systems Biology in Reproductive Medicine
- Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
- (2013) B. Flourié et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - a placebo-controlled study
- (2013) M. Watanabe et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pericarditis aguda asociada al tratamiento con mesalazina oral o tópica en pacientes con colitis ulcerosa
- (2013) Margalida Calafat et al. Gastroenterologia y Hepatologia
- Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
- (2012) Geert D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Can oral 5-aminosalicylic acid be administered once daily in the treatment of mild-to-moderate ulcerative colitis? A meta-analysis of randomized-controlled trials
- (2012) Ying Zhu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis
- (2012) Brian G. Feagan et al. INFLAMMATORY BOWEL DISEASES
- Recurrence of Myocarditis After Mesalazine Treatment for Ulcerative Colitis
- (2012) Tony Sabatini et al. INFLAMMATORY BOWEL DISEASES
- Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: A meta-analysis
- (2012) Jin Lu TONG et al. Journal of Digestive Diseases
- Mesalamine in the treatment and maintenance of remission of ulcerative colitis
- (2012) Maggie Ham et al. Expert Review of Clinical Pharmacology
- An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
- (2011) Nicholas J Talley et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Recurrent myopericarditis with extensive ulcerative colitis
- (2011) Hugh James Freeman et al. CANADIAN JOURNAL OF CARDIOLOGY
- Mesalazine-induced bronchiolitis obliterans organizing pneumonia (BOOP) in a patient with ulcerative colitis and primary sclerosing cholangitis
- (2011) D. Kevans et al. INFLAMMATORY BOWEL DISEASES
- Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
- (2010) W. Kruis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
- (2010) Asher Kornbluth et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pneumopathie interstitielle induite par la mésalazine
- (2010) T. Lamsiah et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
- (2010) William J. Sandborn et al. GASTROENTEROLOGY
- Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
- (2010) Hiroaki Ito et al. INFLAMMATORY BOWEL DISEASES
- Clinical trial: effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study
- (2010) Nobuo Hiwatashi et al. JOURNAL OF GASTROENTEROLOGY
- Differential diagnosis problem of pulmonary changes in ulcerative colitis
- (2010) Mirna Djuric et al. Vojnosanitetski Pregled
- Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX®with Asacol®
- (2009) C. PRANTERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
- (2009) Axel U. Dignass et al. Clinical Gastroenterology and Hepatology
- Myocarditis by mesalazine with cardiac magnetic resonance imaging
- (2009) Luis García-Ferrer et al. EUROPEAN HEART JOURNAL
- Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Current Surgical Management of Ulcerative Colitis
- (2009) Alexis Grucela et al. MOUNT SINAI JOURNAL OF MEDICINE
- Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
- (2008) W Kruis et al. GUT
- Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
- (2008) M A Kamm et al. GUT
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started